Network variation - DNA adduct formation (cancer)
[
Network menu
|
Network entry
|
Help
]
ENTRY
nt06250
Name
DNA adduct formation (cancer)
Category
Disease view; Cancer signaling
Display
drug-target relation
disease type
N01369
4-ABP
−
CYP1A2
⇉
NAT1
→
N-OAc-ABP
=
DNA
N01370
PhIP
−
CYP1A2
⇉
NAT2
→
N-OAc-PhIP
=
DNA
N01371
PhIP
−
CYP1A2
⇉
SULT1A
→
N-sulfonyloxy-PhIP
=
DNA
N01372
IQ
−
CYP1A2
⇉
(
NAT1
,
NAT2
)
→
N-Acetoxy-IQ
=
DNA
N01373
MeIQx
−
CYP1A2
⇉
NAT2
→
N-Acetoxy-MeIQx
=
DNA
N01374
BaP
−
(
CYP1A1
,
CYP1B1
)
⇉
EPHX1
⇉
(
CYP1A1
,
CYP1B1
)
→
BPDE
=
DNA
N01375
DMBA
−
CYP1A1
⇉
EPHX1
⇉
CYP1A1
→
DMBADE
=
DNA
N01376
Melphalan
=
DNA
N01377
Thiotepa
=
DNA
N01378
AFB1
−
(
CYP3A4
,
CYP1A2
)
→
AFB1-exo-8,9-epoxi..
=
DNA
N01379
NNK
−
(
CYP2A6
,
CYP2A13
)
→
C19563
→
C19564
=
DNA
N01380
NNK
−
(
CYP2A6
,
CYP2A13
)
→
C19566
→
C19568
→
C20302
=
DNA
N01381
NNK
−
(
AKR1C2
,
CBR1
,
HSD11..
⇉
(
CYP2A6
,
CYP2A13
)
→
C19577
→
C19568
→
C20302
=
DNA
N01382
NNK
−
(
AKR1C2
,
CBR1
,
HSD11..
⇉
(
CYP2A6
,
CYP2A13
)
→
C19580
→
C19581
=
DNA
N01383
NMDA
−
CYP2E1
→
C20301
→
C20302
=
DNA
N01384
EO
=
DNA
N01385
VC
−
CYP2E1
→
CEO
=
DNA
N01386
DCE
−
GST
→
C20304
→
C14874
=
DNA
N01387
SM
=
DNA